Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluation of the Immunosafety of Cucurbit[n]uril In Vivo.
Pashkina E, Aktanova A, Boeva O, Bykova M, Gavrilova E, Goiman E, Kovalenko E, Saleh N, Grishina L, Kozlov V. Pashkina E, et al. Among authors: gavrilova e. Pharmaceutics. 2024 Jan 19;16(1):127. doi: 10.3390/pharmaceutics16010127. Pharmaceutics. 2024. PMID: 38276497 Free PMC article.
Early mobilisation in critically ill COVID-19 patients: a subanalysis of the ESICM-initiated UNITE-COVID observational study.
Kloss P, Lindholz M, Milnik A, Azoulay E, Cecconi M, Citerio G, De Corte T, Duska F, Galarza L, Greco M, Girbes ARJ, Kesecioglu J, Mellinghoff J, Ostermann M, Pellegrini M, Teboul JL, De Waele J, Wong A, Schaller SJ; ESICM UNITE COVID Investigators. Kloss P, et al. Ann Intensive Care. 2023 Nov 14;13(1):112. doi: 10.1186/s13613-023-01201-1. Ann Intensive Care. 2023. PMID: 37962748 Free PMC article.
Epidemiology of Zoonotic Coxiella burnetii in The Republic of Guinea.
Ohlopkova OV, Yakovlev SA, Emmanuel K, Kabanov AA, Odnoshevsky DA, Kartashov MY, Moshkin AD, Tuchkov IV, Nosov NY, Kritsky AA, Agalakova MA, Davidyuk YN, Khaiboullina SF, Morzunov SP, N'Fally M, Bumbali S, Camara MF, Boiro MY, Agafonov AP, Gavrilova EV, Maksyutov RA. Ohlopkova OV, et al. Among authors: gavrilova ev. Microorganisms. 2023 May 29;11(6):1433. doi: 10.3390/microorganisms11061433. Microorganisms. 2023. PMID: 37374935 Free PMC article.
Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III).
Ryzhikov AB, Ryzhikov EA, Bogryantseva MP, Usova SV, Nechaeva EA, Danilenko ED, Pyankov SA, Gudymo AS, Moiseeva AA, Onkhonova GS, Pyankov OV, Sleptsova ES, Lomakin NV, Vasilyeva VS, Tulikov MV, Gusarov VG, Pulin AA, Balalaeva MA, Erofeeva SB, Terpigorev SA, Rychkova OA, Petrov IM, Delian VY, Rafalskiy VV, Tyranovets SV, Gavrilova EV, Maksyutov RA. Ryzhikov AB, et al. Among authors: gavrilova ev. Vaccines (Basel). 2023 May 18;11(5):998. doi: 10.3390/vaccines11050998. Vaccines (Basel). 2023. PMID: 37243102 Free PMC article.
A phase 1b study of the allosteric extracellular FGFR2 inhibitor alofanib in patients with pretreated advanced gastric cancer.
Tsimafeyeu I, Statsenko G, Vladimirova L, Besova N, Artamonova E, Raskin G, Rykov I, Mochalova A, Utyashev I, Gorbacheva S, Kazey V, Gavrilova E, Dragun N, Moiseyenko V, Tjulandin S. Tsimafeyeu I, et al. Among authors: gavrilova e. Invest New Drugs. 2023 Apr;41(2):324-332. doi: 10.1007/s10637-023-01340-z. Epub 2023 Mar 13. Invest New Drugs. 2023. PMID: 36907947 Clinical Trial.
148 results